Literature DB >> 22446648

[Normal plasma insulin and HOMA values among Chilean children and adolescents].

Salesa Barja1, Pilar Arnaiz, Angélica Domínguez, Luis Villarroel, Berta Cassis, Oscar Castillo, Gianina Salomó, Marcelo Farías, Manuela Goycoolea, Teresa Quiroga, Francisco Mardones.   

Abstract

BACKGROUND: Plasma insulin and HOMA (homeostasis model assessment) index, used to determine insulin resistance, do not have local standard values for children and adolescents in Chile. AIM: To establish the normal reference intervals for insulin and HOMA in children and adolescents aged 10-15 years, according to sex and puberal maturation.
MATERIAL AND METHODS: A cross-sectional study of 2,153 children and adolescents from Puente Alto County was performed, during 2009 and 2010. Anthropometry and self-report of puberal maturation were assessed. Fasting glucose (hexoquinase) and insulin blood levels (chemiluminiscence), were determined and HOMA index was calculated. Percentile distributions of these variables were calculated.
RESULTS: The reference group included only subjects with normal body mass index and fasting blood glucose (n = 1,192). Girls had higher insulin and HOMA values than boys (12.5 ± 6.0 and 9.1 ± 4.9 μϋ/mL (p < 0.01) and 2.7 ± 1.4 and 2.1 ± 1,1 (p < 0.01), respectively). Subjects with Tanner I and II pubertal stages had lower insulin and HOMA mean values than subjects with Tanner III and IV (9.0 ± 4.3 and 12.5 ± 6.2μϋ/ml (p < 0.01) and2.0 ± 1 and2.8 ± 1.4 (p < 0.01), respectively).
CONCLUSIONS: The 90th percentile of insulin and HOMA distributions according to sex and maturation, was selected as the upper cut-off point to identify individuals with insulin resistance. HOMA cutoff point for Tanner I and II boys was 3.2, for Tanner I and II girls was 4.1, for Tanner III and IV boys was 4.2 and for Tanner III and IV girls was 5.0.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22446648     DOI: /S0034-98872011001100007

Source DB:  PubMed          Journal:  Rev Med Chil        ISSN: 0034-9887            Impact factor:   0.553


  6 in total

1.  Percentiles of fasting serum insulin, glucose, HbA1c and HOMA-IR in pre-pubertal normal weight European children from the IDEFICS cohort.

Authors:  J Peplies; D Jiménez-Pavón; S C Savva; C Buck; K Günther; A Fraterman; P Russo; L Iacoviello; T Veidebaum; M Tornaritis; S De Henauw; S Mårild; D Molnár; L A Moreno; W Ahrens
Journal:  Int J Obes (Lond)       Date:  2014-09       Impact factor: 5.095

2.  Associations of prenatal growth with metabolic syndrome, insulin resistance, and nutritional status in Chilean children.

Authors:  Francisco Mardones; Pilar Arnaiz; Paz Pacheco; Angelica Dominguez; Luis Villarroel; Johan G Eriksson; Salesa Barja; Marcelo Farías; Oscar Castillo
Journal:  Biomed Res Int       Date:  2014-06-15       Impact factor: 3.411

3.  Metabolically healthy overweight adolescents: definition and components.

Authors:  António Videira-Silva; Silvia Freira; Helena Fonseca
Journal:  Ann Pediatr Endocrinol Metab       Date:  2020-12-31

4.  Impact of Insulin Resistance on Cardiometabolic Risk Factors and an Anthropometry-Based Predictive Nomogram for Insulin Resistance Among Adolescents in China.

Authors:  Runyu Du; Ling Li; Ping Li; Yanjun Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-28       Impact factor: 5.555

5.  Metabolic syndrome risk factors in overweight, obese, and extremely obese Brazilian adolescents.

Authors:  Anapaula Cb Rizzo; Tamara Bl Goldberg; Carla C Silva; Cilmery S Kurokawa; Helio Rc Nunes; José E Corrente
Journal:  Nutr J       Date:  2013-01-30       Impact factor: 3.271

6.  The Influence of Obesity on Puberty and Insulin Resistance in Mexican Children.

Authors:  Edith Cardenas-Vargas; Jairo A Nava; Idalia Garza-Veloz; Mayra C Torres-Castañeda; Carlos E Galván-Tejada; Miguel A Cid-Baez; Rosa E Castañeda-Arteaga; Yolanda Ortiz-Castro; Perla M Trejo-Ortiz; Roxana Araujo-Espino; Fabiana E Mollinedo-Montaño; Jose R Muñoz-Torres; Margarita L Martinez-Fierro
Journal:  Int J Endocrinol       Date:  2018-09-03       Impact factor: 3.257

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.